Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

Rhea-AI Summary

Prestige Consumer Healthcare (NYSE:PBH) has announced its participation in the Barclays Global Consumer Staples Conference on Thursday, September 5, 2024, at 2:15 p.m. ET. The company will present at this significant industry event, offering insights into its operations and strategy.

Interested parties can access a live webcast of the presentation through the company's official website under the 'Investors' section and 'Events and Presentations' tab. For those unable to attend the live event, a replay option will be available on the company's website following the presentation. This announcement highlights Prestige Consumer Healthcare's commitment to investor relations and transparency in its business operations.

News Market Reaction – PBH

-0.74%

1 alert

-0.74% News Effect

On the day this news was published, PBH declined 0.74%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

TARRYTOWN, N.Y., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 5, 2024 at 2:15 p.m. ET.  All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:

https://ir.prestigebrands.com/events-presentations/events

For those unable to participate during the live webcast, a replay option will be available on the Company’s website following the event.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is a leading consumer healthcare products company with sales throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse and iconic portfolio of brands include Monistat^® and Summer’s Eve^® women's health products, BC^® and Goody's^® pain relievers, Clear Eyes^® and TheraTears^® eye care products, DenTek^® specialty oral care products, Dramamine^® motion sickness treatments, Fleet^® enemas and glycerin suppositories, Chloraseptic^® and Luden's^® sore throat treatments and drops, Compound W^® wart treatments, Little Remedies^® pediatric over-the-counter products, Boudreaux’s Butt Paste^® diaper rash ointments, Nix^® lice treatment, Debrox^® earwax remover, Gaviscon^® antacid in Canada, and Hydralyte^® rehydration products and the Fess^® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.

FAQ

When is Prestige Consumer Healthcare (PBH) presenting at the Barclays Global Consumer Staples Conference?

Prestige Consumer Healthcare (PBH) is presenting at the Barclays Global Consumer Staples Conference on Thursday, September 5, 2024, at 2:15 p.m. ET.

How can investors access the live webcast of Prestige Consumer Healthcare's (PBH) presentation?

Investors can access the live webcast of Prestige Consumer Healthcare's (PBH) presentation through the company's website at www.prestigeconsumerhealthcare.com under the 'Investors' section and 'Events and Presentations' tab.

Will there be a replay available for Prestige Consumer Healthcare's (PBH) Barclays Conference presentation?

Yes, a replay option will be available on Prestige Consumer Healthcare's (PBH) website following the live presentation at the Barclays Global Consumer Staples Conference.

What is the stock symbol for Prestige Consumer Healthcare mentioned in the press release?

The stock symbol for Prestige Consumer Healthcare mentioned in the press release is PBH, listed on the New York Stock Exchange (NYSE:PBH).